期刊文献+

靛玉红衍生物结构与抗肿瘤活性关系预测方程的建立 被引量:2

An Equation for Predicting the Anti-tumor Activity of Indirubin Derivatives by Study of QSAR
下载PDF
导出
摘要 目的:建立一个方程,用于预测靛玉红衍生物(主要为靛玉红-3′-肟类)的体外抗肿瘤活性。方法:采用经典的二维定量构效关系研究方法,对24个靛玉红衍生物进行计算机模拟与统计分析。结果:得到靛玉红衍生物体外抗肿瘤活性的定量构效方程,且发现,该类靛玉红衍生物的活性与脂水分配系数、偶极矩、总电荷绝对值和最大负电荷呈负相关,与分子体积呈正相关。结论:所得方程能有效预测该类靛玉红衍生物的活性,且对其类似物的设计与改造具有指导意义。 Objective:To establish an equation for predicting the quantitative structure-activity rela-tionship (QSAR) of indirubin derivatives (mainly indirubin-3'-monoxime) which have anti-tumor activity in vitro.Methods:The 2D QSAR method was used to conduct the simulation and statistical analysis with 24 indirubin derivatives on computer.Results:The QSAR equation of indirubin derivatives was acquired.There was a positive correlation between the anti-tumor activity and the logP,dipole,absolute value of the total charge and maximum negative charge,respectively;there was a negative correlation between the anti-tumor activity and molecular volume.Conclusion:The QSAR equation is useful for predicting the activity of indirubin derivatives,and it is also helpful for designing and reforming the related analogs.
出处 《药学进展》 CAS 2010年第7期324-328,共5页 Progress in Pharmaceutical Sciences
基金 江苏省高校研究生创新计划资助项目(No.CX08S-031Z)
关键词 靛玉红衍生物 靛玉红-3′-肟 定量构效关系 抗肿瘤活性 indirubin derivatives indirubin-3'-monoxime QSAR anti-tumor activity
  • 相关文献

参考文献9

  • 1Zheng L,Lee W H.The retinoblastoma gene:a prototypic and multifunctional tumor suppressor[J].Exp Cell Res,2001,264(1):2-18.
  • 2Haripriya V R,Lakshmi T,Paula G.Cyclin C and cyclin dependent kinases 1,2 and 3 in thrombin-induced neuronal cell cycle progression and apoptosis[J].Neurosci Lett,2009,450(3):347-350.
  • 3Kapuy O,He E,López-Avilés S,et al.System-level feedbacks control cell cycle progression[J].FEBS Lett,2009,583(24):3992-3998.
  • 4Hardcastle I R,Golding B T,Griffin R J.Designing inhi-bitors of cyclin-dependent kinases[J].Annu Rev Pharmacol Toxicol,2002,42(2):325-348.
  • 5Buolamwini J K.Cell cycle molecular targets in novel anticancer drug discovery[J].Curr Pharm Des,2000,6(4):379-392.
  • 6Hoessel R,Leclerc S,Endicott J A,et al.Indirubin,the active constituent of a Chinese antileukaemia medicine,inhibits cyclin-dependent kinases[J].Nat Cell Biol,1999,1(1):60-67.
  • 7Marko D,Sch(a)tzle S,Friedel A,et al.Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells[J].Br J Cancer,2001,84(2):283-289.
  • 8Moon M J,Lee S K,Lee J W,et al.Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities[J].Bioorg Med Chem,2006,14(1):237-246.
  • 9王朝晖,王越,冯明声,谭雪,程景才,华维一,姚其正.N^1-烃基-3'-肟基靛玉红的简便合成、晶体结构及抗肿瘤活性研究[J].有机化学,2009,29(10):1606-1610. 被引量:1

二级参考文献2

同被引文献22

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部